GnRH-agonist versus GnRH-antagonist IVF cycles: is the reproductive outcome affected by the incidence of progesterone elevation on the day of HCG triggering? A randomized prospective study.
about
Gonadotrophin-releasing hormone antagonists for assisted reproductive technologyOvarian hyperstimulation syndrome: pathophysiology, staging, prediction and preventionComparisons of GnRH antagonist protocol versus GnRH agonist long protocol in patients with normal ovarian reserve: A systematic review and meta-analysisComparisons of GnRH antagonist versus GnRH agonist protocol in supposed normal ovarian responders undergoing IVF: a systematic review and meta-analysis.Comparison of results of cycles treated with modified mild protocol and short protocol for ovarian stimulation.Ratio of progesterone-to-number of follicles as a prognostic tool for in vitro fertilization cyclesFactors influencing serum progesterone level on triggering day in stimulated in vitro fertilization cycles.Progesterone/Estradiol Ratio as a Predictor in the ART Cycles with Premature Progesterone Elevation on the Day of hCG Trigger.Endometrial pattern, but not endometrial thickness, affects implantation rates in euploid embryo transfersRelationship between progesterone level on the day of human chorionic gonadotropin administration with outcomes of intra-cytoplasmic sperm injection in infertile couples.A modified ultra-long pituitary downregulation protocol improved endometrial receptivity and clinical outcome for infertile patients with polycystic ovarian syndrome.Progesterone change in the late follicular phase affects pregnancy rates both agonist and antagonist protocols in normoresponders: a case-controlled study in ICSI cyclesComparison of the GnRH agonist and antagonist protocol on the same patients in assisted reproduction during controlled ovarian stimulation cycles.Comparative multiplex analysis of cytokines, chemokines and growth factors in follicular fluid of normoresponder women undergoing ovum donation with gonadotropin-releasing hormone agonist versus gonadotropin-releasing hormone antagonist protocols.Quantifying the biomechanics of conception: L-selectin-mediated blastocyst implantation mechanics with engineered "trophospheres".Effects of high progesterone on outcomes of in vitro fertilization-embryo transfer in patients with different ovarian responses.Blastocyst transfer does not improve cycle outcome as compared to D3 transfer in antagonist cycles with an elevated progesterone level on the day of hCG.The effect of 24 hours delay in oocyte maturation triggering in IVF/ICSI cycles with antagonist protocol and not-elevated progesterone: A randomized control trial.GnRH antagonist versus long agonist protocols in IVF: a systematic review and meta-analysis accounting for patient type.Fertility Treatment Outcomes After Follicle Tracking With Standard 2-Dimensional Sonography Versus 3-Dimensional Sonography-Based Automated Volume Count: Prospective Study.Is measurement of progesterone level prior to FSH stimulation useful in GnRH-antagonist cycles?The Impact of Progesterone Level on Day Of hCG Injection in IVF Cycles on Clinical Pregnancy Rate.Laparoscopic ovarian drilling versus GnRH antagonist combined with cabergoline as a prophylaxis against the re-development of ovarian hyperstimulation syndrome.A Proof-of-Concept Clinical Trial of A Single Luteal Use of Long-Acting Gonadotropin-Releasing Hormone Antagonist Degarelix in Controlled Ovarian Stimulation for In Vitro Fertilization: Long Antagonist Protocol.Endogenous luteinizing hormone concentration and IVF outcome during ovarian stimulation in fixed versus flexible GnRH antagonist protocols: An RCT.The curious case of premature luteinizationBasal progesterone level as the main determinant of progesterone elevation on the day of hCG triggering in controlled ovarian stimulation cycles
P2860
Q24185849-C4D459BC-BAF4-4029-A22E-A02870D9C28CQ26827593-7AC91F2E-A2E1-4CE5-80C4-7BD528A38295Q33596777-AE612BF2-5B66-41C3-B3AC-D8B37A075366Q34172380-72FD9E3D-5419-42DD-A147-A007B2718FD7Q35100104-B8B22C3B-5F0E-4394-AD1E-440231EB5DB5Q35816175-A46976F1-D3FC-4D8C-A797-25AEDE89DC5DQ35833297-6F1529BA-8FEC-4B84-B09A-70D0EAF516D2Q35868487-E041FF20-2458-4EE0-99E0-27C9B5AF80D8Q36030901-F4518082-3879-438B-9F52-9E4B11131539Q36172763-CEAD8849-F938-4AFD-9E44-36001261752BQ36336452-B9D0CE67-EFF9-43BA-8B3C-C9DB58A10F07Q36825733-C3D344C9-C6E5-4B4C-9986-52E98393278EQ37138027-224D0759-3449-432D-930D-ACBAE9808B4BQ37370067-67D50EA3-055B-4056-91CC-AAE204808D72Q37419284-103A25DF-0D12-41A7-8693-E3B82D067BA1Q41010556-01042131-A7E6-4E5F-BB06-37089A0551DDQ41522452-C1E8EEBA-E3DB-44F0-84B5-FD2CF815C94DQ45717122-0A3CB871-102F-4B42-97AB-03C0E8F26B83Q47990608-F6DC75EE-9D30-4F17-9D5B-84DD0FA0BC96Q48272194-C59D9B78-FEEB-446A-8682-29B5C980A779Q48578033-8FCAE6D6-A620-4CB5-B623-C65F233D7CDBQ49412101-209191DB-1262-4B6F-A108-0716B7B0F4D0Q50046268-0DF0C379-6FDA-4EE0-93EC-BAF9F1C00880Q52653133-8E4E80C2-10BC-4EDB-8C00-3D5364F99F5FQ55072129-F80FB7CA-D1D1-426E-B444-56C5CBE10061Q57141004-A9B9F5C7-FD8F-48E2-AC16-0859D1786C57Q58860558-F1483A83-C028-44F7-9449-BC2DE831BA9F
P2860
GnRH-agonist versus GnRH-antagonist IVF cycles: is the reproductive outcome affected by the incidence of progesterone elevation on the day of HCG triggering? A randomized prospective study.
description
2012 nî lūn-bûn
@nan
2012 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի մարտին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
GnRH-agonist versus GnRH-antag ...... randomized prospective study.
@ast
GnRH-agonist versus GnRH-antag ...... randomized prospective study.
@en
GnRH-agonist versus GnRH-antag ...... randomized prospective study.
@nl
type
label
GnRH-agonist versus GnRH-antag ...... randomized prospective study.
@ast
GnRH-agonist versus GnRH-antag ...... randomized prospective study.
@en
GnRH-agonist versus GnRH-antag ...... randomized prospective study.
@nl
prefLabel
GnRH-agonist versus GnRH-antag ...... randomized prospective study.
@ast
GnRH-agonist versus GnRH-antag ...... randomized prospective study.
@en
GnRH-agonist versus GnRH-antag ...... randomized prospective study.
@nl
P2093
P2860
P356
P1433
P1476
GnRH-agonist versus GnRH-antag ...... A randomized prospective study
@en
P2093
B Tarlatzis
E G Papanikolaou
G Grimbizis
N P Polyzos
P2860
P304
P356
10.1093/HUMREP/DES066
P407
P577
2012-03-14T00:00:00Z